InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2022 Results, Provide Business Update
Nov 21, 2022
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide life sciences and other industries. The company today announced that it will host a teleconference to discuss its third quarter 2022 financial results and to provide a business update. The event will be followed by a question-and-answer period. Interested parties may join the live call by dialing (888) 506-0062 (North America) or (973) 528-0011 (international) and entering verbal access code 521494 (or by saying Pressure BioSciences Q3 conference call). For those unable to participate in the live teleconference, a replay will be available via the company’s website or by telephone as detailed in the announcement.
To view the full press release, visit https://ibn.fm/tEFg0
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) patented technology from BaroFold Inc. (the BaroFold technology) that allows entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
More News
Gillingham strikers on the money in clinical Rotherham rout
Gillingham’s strikers earned their money at Rotherham with a clinical display in front of goal.
Comeback Kings progress with FA Vase win
Seven Southern Counties East sides progressed to the second round of the FA Vase on Saturday.
Three-way tie at league summit
Dartford are one of three teams locked on 24 points at the top of the Isthmian Premier after Louie Atkins’ late winner against Wingate & Finchley.
Report: Gillingham hit four goals at Rotherham in comeback win
Gillingham fought back from a goal down to thrash Rotherham United on Saturday.
Matchday Live: Rotherham v Gillingham, Hampton v Ebbsfleet, Horsham v Maidstone
Follow this afternoon’s football, including Gillingham’s match at Rotherham, in our live blog.
Former Gillingham defender finds new club after summer exit
Former Gillingham defender Max Clark has joined a team at the lower end of the National League.
Ainsworth highlights Dack’s importance after Gillingham milestone
Bradley Dack reached 250 Gillingham appearances last weekend – and boss Gareth Ainsworth insists the midfielder remains a big part of the club.
Brophy’s two-position form creates Gillingham selection dilemma
James Brophy has given Gillingham boss Gareth Ainsworth a selection dilemma ahead of Conor McManus’ return from international duty.
Gillingham waiting on McManus fitness after Ireland outing
Gillingham will need to check on the status of defender Conor McManus before deciding whether he will travel this weekend.
Gillingham youngster’s frustrating start explained by Ainsworth
Gillingham are continuing to manage an injury that has restricted Sam Tabares’ start to life at Priestfield.
Gareth Ainsworth makes bold Gillingham claim
Manager Gareth Ainsworth believes his Gillingham team are the real deal this season.
Football fixtures and results
Catch up with all the week’s football fixtures and results here.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.